Ulje Harlem
In 1924, Haarlem Oil is already use in France. It has a monograph from Vidal which was viewed by the Alexandre Commission, Star Monograph 1981.
Tvar sumpornih terpena, u kojoj su svojstva komponenata, oksidi organskog sumpora, terpenska esencija iz terpentina, ima snažno antiseptičko djelovanje povezano sa svojstvima terpentinske esencije.
Bilo je modificiranih postupaka koji su razjašnjeni iz brojnih sekreta, posebno bronhijalnih povezanih sa sumporom.
The diffusion of Haarlem Oil is large in the organism, it as experimentally shown by pharmacological studies. Its benefits are aimed at the digestive absorption, biliary elimination, tissue distribution, constant plasma and excretion of S35 in rats, after a unique oral dose of Haarlem Oil with therapeutic dose of 10mg/kg.
Studija profesora Jacquota (1984) pokazuje važnu raspodjelu tkiva i prerano, 15 minuta i sat vremena, na nivou bronhijalno-plućnih tkiva. Protuupalno djelovanje je eksperimentalno, kako je izvješteno u studiji profesora Jacquota (1986), koja primjećuje značajno povišeno djelovanje superoksid dismutaze (SOD), vjerovatno povišenjem tiola u plazmi. Odsustvo toksičnosti u ulju Haarlem olakšava tri reda utvrđenih činjenica.
The diffusion of sulfur and pine terpene is great in the organism, it show experimentally by pharmacological studies. Its benefits are aimed at digestive absorption, biliary elimination, tissue distribution, constant plasma and excretion of S35 in rats, after a single oral dose of Haarlem oil with the therapeutic dose of 10 mg / kg
There are no case of intoxication of Haarlem Oil been report since it has been on the market.
Rizik od slučajne intoksikacije nije postojao, uglavnom kod djece.
Haarlem Oil is available in 2 forms:
U bočici od 10 ml
U kapsulama, kutija od 30 kapsula, 6.4g
Neka djeca sažvaču tabletu i odmah je ispljunu zbog jakog ukusa proizvoda. Zbog toga je specijalitet bio jako zaslađen.
Metodologija kliničkih studija
Doziranje:
Haarlem Oil is prescrib at a dose of 10mg per kilo for an initial cure of 10 days. Eventually, to repeat for 8 to 10 days per month, if necessary.
Način administracije:
U obliku kapi pomiješanih sa slatkom hranom.
Izbor pacijenata:
Nakon pruženih informacija i pristanka njihovih roditelja, 25 djece je podvrgnuto liječenju uljem Haarlem.
Dob djece:
Starost djece bila je između 5 mjeseci i 8 godina.
Svi pacijenti imali su kliničke simptome različitog etiološkog kroničnog bronhitisa koji su prijavljeni u pojedinačnim datotekama i sintetizirani u priloženoj tablici.
Propisano je ulje Harlem, isključujući bilo koji drugi tretman koji modificira sluz.
napomene:
Primjećuje se da su samo kod 2 pacijenta procjene dopuštale olakšanje sa vrlo pozitivnog alergijskog tla.
Commentaries
Rezultati, kako su izvijestile kliničke studije na 25 djece, potvrđuju interes upotrebe haarlemskog ulja u liječenju kroničnih bronhijalno-plućnih infekcija.
Nedavne publikacije jasno su nam pokazale da djelotvornost onoga što se nazivalo "eskalatorom sluzi-cilijarni" ovisi ne samo o integritetu ćelija epitela, koordinaciji i kretanju cilijara, već i o karakterima nosoroga sluzi u kojima niti i viskoelastičnost se mijenjaju i smanjuju u slučajevima ponavljajućih bronhijalno-plućnih infekcija.
Stoga je opravdanje upotrebe ulja Haarlem sljedeće:
- Znanje o njegovim svojstvima da modificiraju sluz i plućnim antiseptikama bilo je poznato vrlo dugo.
- Odsustvo toksičnosti.
Nedavni eksperimenti izvedeni na životinjama imaju odobrenje i daju ljudskim bićima bioraspoloživost i identično djelovanje, uz važnu fiksaciju sumpora u tkivu na nivou bronhijalno-plućne.
Our studies have been based on simple observations of clinical signs and on evolution. It is difficult, according to the opinion of , to have a large scale of controlled tests appreciating panacea and the effectiveness of mucus-modification, for the reason of diverse etiologies competing with chronic bronchial-pulmonary pathologies and the fact of complex complementary explorations. For these reasons, we have chosen the clinical appreciations and evolution, compared to other products, currently proposed in the treatment of these symptoms.
In 68% of the cases in our series, we observed since the first treatment of Haarlem Oil, the clarification and the disappearance of bronchial hyper-secretion, in less than one week. This confirms the positive rheological action of the antiseptic action of Haarlem Oil. These actions continued with remnants after several weeks, in the majority of the cases. In 70% of children, for which the renewing of the treatment of Haarlem Oil was proposed monthly, effectiveness followed favorably, bringing a total recovery of chronic bronchial-pulmonary, in less than four months. We can measure the savings also realized by the multiple treatments previously used (particularly the repeated antibiotic treatments). In the other cases, 60% of which the monthly cures continue systematically or by request, the antiseptic action and clarification of tracheal-bronchitis secretion were shown. Haarlem Oil obtained the disappearance of all congestion symptoms during the long periods and has also significantly reduced the episodes of secondary infection, uniquely observed in children, in which the attack of chronic bronchial-pulmonary was considered as definitive.
Oslobađanju leukotriena od strane makrofaga pogodovalo je njihovo bronhijalno-strukturno djelovanje, zadržavanje u zračnom prolazu. Uloga toksičnih metabolizma kiseonika koji nastaju kao posljedica respiratornih posljedica važnija je od antioksidativnog sustava novorođenčadi koja je nezrela.
Therefore, the study of C. Jacquot appears that it is essential. It has demonstrated, in animals, the antioxidant activity of Haarlem Oil. The activity of the Superoxide Dismutase (SOD) enzyme, principal antioxidant enzyme of the organism, is significantly higher in the cases cure by Haarlem Oil, than in the witness groups. This increases report an elevation of thiols groups in the plasma.
zaključci
Used in 25 children that were infected with chronic bronchial-pulmonary of diverse etiologies, Haarlem Oil has shown a good effect in 68% of the cases, since the first treatment, and in 70% of the cases, where the treatment was renewed monthly, the reduction and disappearance of clinical symptoms of bronchial hypersecretion. This action was clearly superior to the mucus-modifying medication, comparably prescribed habitually.
It is desirable that the studies continue particularly at the pharmacological level, next to the antiseptic actions and classic mucus-modifications known of Haarlem Oil. The antioxidant activity brought into evidence, the elevation of the activity of the Superoxide Dismutase (SOD), essential appearance in the prevention of pulmonary bronchial-dysplasia.